IPAR NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Inter Parfums Inc · Consumer Defensive · Household & Personal Products

Open interactive chart View report data
Latest close 124.5 USD
1.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 26.0% above the Trend Line and sits at 91.2% of its 52-week range. The latest completed week returned 1.6%, after a 4.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 38/100 conviction, while the latest news-sentiment score is 61/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal; earnings are due in 3d.

Setup score 64 out of 100
Latest Close 124.5 USD 31 Jul 2026
1W Return 1.6% latest completed week
4W Return 4.3% short-term follow-through
12W Return 32.9% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 17-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 42.46% based on similar historical setup states.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.6% Latest completed week; four-week move 4.3%. Indicator stack 63/78 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.46% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 38/100 conviction; expected move 7.3%. News sentiment 61/100 34 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 26.0% above the Trend Line and sits at 91.2% of its 52-week range. The latest completed week returned 1.6%, after a 4.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7412-week average 0.45

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.74Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 4.3% over four weeks, 32.9% over 12 weeks, and 8.9% over one year. The current trend has remained active for 17 consecutive weeks.

Performance by holding period

1W1.6%
4W4.3%
12W32.9%
26W29.8%
52W8.9%
Active trend streak17 weeks
Active weeks in one year17
Trend breadth32.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.51Latest activity-pressure read.
Pressure change11.1%Four-week change in activity pressure.
Leadership17.98Latest relative-leadership reading.
RS change162.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength29/100Blend of value, momentum, and quality. Underlying universe rank 72; rank 1 is best.
Value24/100Relative valuation strength. Underlying universe rank 77; rank 1 is best.
Quality86/100Profitability and accounting quality. Underlying universe rank 15; rank 1 is best.
Momentum27/100Medium-term price momentum. Underlying universe rank 74; rank 1 is best.
Growth68/100Revenue and earnings growth. Underlying universe rank 33; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework61/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
23.2x
Price divided by trailing earnings.
Price / sales
2.6x
Market value relative to trailing revenue.
EV / EBITDA
13.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
64.0%
Gross profit retained from each unit of revenue.
Operating margin
18.8%
Operating profit retained from revenue.
Free-cash-flow margin
16.4%
Free cash flow generated from revenue.
Return on invested capital
21.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.9%
Latest one-year revenue growth.
EPS growth
2.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-11.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.6%
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
2.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

IPAR shows bullish options pressure with a 38/100 conviction score, put-call volume ratio of 0.67, expected move of 7.3%, and Sharemaestro trend signal active.

Conviction38/100
Expected move7.3%
Put/call volume0.67
Pressure29
Speculation9
Volatility54
Trend agreement71
Open options detail
Insider activity0 / 1

0 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment61/100

Weighted news tone is neutral across 34 relevant articles.

18 positive · 15 neutral · 1 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move7.3%Nearest-chain priced movement where available.
52-week drawdown-3.7%Distance below the 52-week high.
13-week volatility5.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+11.5%Week of 12 Jun.
Worst week-8.8%Week of 15 May.
Latest week+1.6%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains9
Flat weeks0
Modest losses8
Sharp losses3
Recent vol5.6%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape61/100

Trend, activity pressure, participation, and risk combine to a 61/100 tape read.

 Indicator analysis67/100

Latest 12-week confirmation: trend 12/12, activity pressure 7/12, relative leadership 5/12.

Activity pressure 0.74; No reversal markers Next-Week ExpectancyNegative 42.46%

Next-week expectancy is negative with a 42.46% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors41/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 38; Small Cap Core rank 77 SVQF61/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 280.5 of 726 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options61/100

IPAR shows bullish options pressure with a 38/100 conviction score, put-call volume ratio of 0.67, expected move of 7.3%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 7.3% Sentiment61/100

Weighted news tone is neutral across 34 relevant articles.

Interparfums Q3 EPS Estimate Decreased by Zacks Research Insiders0 / 1

0 acquisitions and 1 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026124.5 USD1.6%98.88 USD113.5 USD1.5117.981.2MOn
24 Jul 2026122.5 USD-0.6%97.53 USD113.6 USD1.6616.341.1MOn
17 Jul 2026123.2 USD3.3%96.25 USD113.7 USD1.8414.711.6MOn
10 Jul 2026119.3 USD-0.1%94.90 USD113.7 USD1.605.802.0MOn
3 Jul 2026119.4 USD10.6%93.66 USD113.7 USD1.366.851.7MOn
26 Jun 2026108.0 USD9.0%92.37 USD113.7 USD0.80-3.422.0MOn
19 Jun 202699.09 USD-1.9%91.41 USD113.8 USD0.24-16.171.1MOn
12 Jun 2026101.0 USD11.5%90.72 USD114.0 USD-0.01-13.441.2MOn
5 Jun 202690.54 USD-3.3%90.19 USD114.2 USD-0.40-21.621.2MOn
29 May 202693.62 USD1.9%90.01 USD114.4 USD-0.36-23.71735.6KOn
22 May 202691.89 USD7.5%89.79 USD114.6 USD-0.32-24.051.3MOn
15 May 202685.47 USD-8.8%89.86 USD114.7 USD-0.33-29.451.3MOn
8 May 202693.73 USD3.0%90.20 USD115.0 USD-0.12-23.861.3MOn
1 May 202691.00 USD0.6%90.08 USD115.2 USD0.02-22.901.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.